Neuphoria Therapeutics Inc. Common Stock (NEUP) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for NEUP. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 21 institutions reported holding NEUP, with 2.0 million shares worth $8.7 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Lynx1 Capital Management | 875,328 | $4M | UNCHANGED |
| Advisorshares Investments | 252,909 | $1M | INCREASED |
| Vanguard | 207,294 | $906K | INCREASED |
| Shay Capital | 155,822 | $681K | INCREASED |
| Balyasny Asset Management | 142,228 | $622K | INCREASED |
Full institutional holdings, insider history, and congressional trades for Neuphoria Therapeutics Inc. Common Stock on SentiSense.